IRIS
GRAVINA, GIOVANNI LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.370
EU - Europa 4.994
AS - Asia 1.954
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 12
AF - Africa 6
SA - Sud America 6
Totale 14.362
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.360
IE - Irlanda 1.517
CN - Cina 1.073
TR - Turchia 814
SE - Svezia 764
IT - Italia 711
DE - Germania 609
GB - Regno Unito 437
UA - Ucraina 436
FI - Finlandia 199
FR - Francia 189
BE - Belgio 72
VN - Vietnam 27
IN - India 20
EU - Europa 18
RU - Federazione Russa 15
AU - Australia 9
NL - Olanda 9
CA - Canada 8
ES - Italia 8
IL - Israele 7
PL - Polonia 4
AT - Austria 3
BR - Brasile 3
CZ - Repubblica Ceca 3
JP - Giappone 3
MA - Marocco 3
NZ - Nuova Zelanda 3
RO - Romania 3
SG - Singapore 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AR - Argentina 2
CH - Svizzera 2
LU - Lussemburgo 2
MK - Macedonia 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BG - Bulgaria 1
DZ - Algeria 1
HU - Ungheria 1
IQ - Iraq 1
LT - Lituania 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 14.362
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.740
Chandler 1.655
Dublin 1.512
Izmir 454
Nanjing 338
Ann Arbor 327
Boardman 319
San Mateo 305
Wilmington 299
L’Aquila 234
Lawrence 232
Princeton 232
New York 212
Ashburn 143
Nanchang 120
Bremen 111
L'aquila 106
Milan 106
Woodbridge 101
Beijing 97
Seattle 91
Shenyang 77
Brussels 72
Hebei 62
Verona 62
Mountain View 58
Kunming 55
Tianjin 54
Des Moines 51
Jiaxing 45
Falls Church 40
Norwalk 37
Changsha 36
Grafing 31
Dearborn 28
Jinan 28
Los Angeles 28
Dong Ket 26
Philadelphia 23
Ningbo 21
Zhengzhou 20
Auburn Hills 18
Lanzhou 17
Helsinki 16
Rome 16
Guangzhou 15
Taizhou 15
Hangzhou 14
Changchun 13
Hanover 12
Shanghai 12
Tappahannock 12
Pune 11
Torre Del Greco 9
Washington 9
Fremont 8
Düsseldorf 7
Strasbourg 7
Napoli 6
Pavia 6
Redwood City 6
Pescara 5
Frankfurt am Main 4
Haikou 4
San Francisco 4
Sydney 4
Buccinasco 3
Controguerra 3
Delhi 3
Edinburgh 3
Florence 3
Fuzhou 3
Hefei 3
Houston 3
London 3
Munich 3
Orange 3
Shaoxing 3
Termoli 3
Tokyo 3
Toronto 3
Turin 3
Vienna 3
Barletta 2
Belgrade 2
Bellante 2
Cambridge 2
Casoria 2
Cedar Knolls 2
Chengdu 2
Cicciano 2
Edmonton 2
Fairfield 2
Groningen 2
Guaymallen 2
Jinhua 2
Lugones 2
Madrid 2
Manchester 2
Melbourne 2
Totale 9.923
Salva come PNG Salva come JPEG
Nome #
640-Slice CT Measurement of Superior Orbital Fissure as Gateway for Light into the Brain: Statistical Evaluation of Area and Distance 196
320-row coronary computed tomography angiography (CCTA) with automatic exposure control (AEC): effect of 100 kV versus 120 kV on image quality and dose exposure 193
From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis 107
C-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines 104
429) Human Endothelial Cells from H(2)O (2) Oxidant Injury Through the Mek/Erk-Sirt1 Axis Activation. 102
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage 101
Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines 98
PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary Cells 96
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 92
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 90
Antiproliferative and pro-apoptotic effects of 5-azacytidine in prostate carcinoma cells in vitro involve the recovering of PTEN-mediated Akt activity control and androgen sensitivity 89
Image quality and radiation dose of single heartbeat 640-slice coronary CT angiography: a comparison between patients with chronic Atrial Fibrillation and subjects in normal sinus rhythm by propensity analysis 88
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro 88
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 87
Bioclinical parameters driving decision-making of subsequent lines of treatment in metastatic castration-resistant prostate cancer 86
Topical application of platelet supernatant gel in the management of radiotherapy-induced mucositis: a case report 86
Moderate hypofractionation in patients with low-risk prostate cancer: Long-term outcomes 85
Trattamento con Casodex ed Iressa nel tumore della prostata: evidenze biologiche a favore 84
Epidemiology of delayed ejaculation 84
Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer 84
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 83
Urodynamic characterization of a female population with clinical SUI and concomitant symptoms suggestive of bladder outlet obstruction 82
Strategies for imaging androgen receptor signaling pathway in prostate cancer: implications for hormonal manipulation and radiation treatment 82
Is Testosterone a Food for the Brain? 82
Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis 81
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer. 81
New approaches in glioblastoma multiforme: The potential role of immune-check point inhibitors 81
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population. 81
Trifluoroibuprofen inhibits α-Methylacyl Coenzyme A Racemase (AMACR/P504S), Reduces Cancer Cell Proliferation and Inhibits in Vivo Tumor Growth in Aggressive Prostate Cancer Models. 80
Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors 79
Cross-cultural and socio-demographic correlates of homophobic attitude among university students in three European countries 79
Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity 78
Combination treatment with solifenacin and tamsulosin in men with overactive bladder (OAB) and bladder outlet obstruction (BOO) 77
Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells 77
Osteoblast-derived TGF beta-1 modulates matrix degrading protease expression and activity in prostate cancer cells (vol 85, pg 407, 2000) 77
Editorial: Antitarget Therapies: New Frontiers in the Treatment of Cancer 76
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells 75
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro 75
EPHRIN A2 ANTAGONISM REDUCES SURVIVAL OF PROSTATE CANCR CELLS AFTER CHEMOTHERAPIC TREATMENTS AND ANGIOGENESIS IN PROSTATE CANCER CELLS BOTH IN VITRO AND IN VIVO 75
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 75
The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study 74
Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pARser81 and CDK1 signaling: biological implications for men treated with testosterone replacement therapy 74
Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis 74
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines 73
L'acido valproico è un potente induttore di apoptosi nelle linee di carcinoma prostatico 73
La ridondanza delle vie di segnalazione intracellulari PI3K-AKT-MTOR induce la resistenza di cellule di cancro prostatico alla terapia ormonale ed ai chemoterapici in vivo ed in vitro 73
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines 73
Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients 73
Role of SIRT1 in the adaptive response of mouse ovaries to radiotherapy (X ray radiations). 73
Treatment of osteolytic solitary painful osseous metastases with radiofrequency ablation or cryoablation: A retrospective study by propensity analysis 73
Urodynamic Obstruction in Women With Stress Urinary Incontinence-Do Nonintubated Uroflowmetry and Symptoms Aid Diagnosis? 73
Treatment of Solitary Painful Osseous Metastases with Radiotherapy, Cryoablation or Combined Therapy: Propensity Matching Analysis in 175 Patients 72
Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways 72
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination 72
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells 72
Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples 71
Alexithymia and vaginismus: a preliminary correlation perspective. 71
Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer 71
Akt protein expression and activation in naive and antihormonal treated prostate cancer tissues 71
Effetto di Getifinib sulla crescita e la formazione di metastasi nel tumore della prostata in vivo 71
Radiofrequency ablation versus magnetic resonance guided focused ultrasound surgery for minimally invasive treatment of osteoid osteoma: a propensity score matching study 71
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases 70
Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative study with erlotinib. 70
Suppression of SRC signaling is effective in reducing synergy between glioblastoma and stromal cells 70
Arachidonic acid sustains prostate tumor growth in bone metastasis through the COX-2-mediated production of TNF-alpha 69
A new inhibitor of EGFR/SRC activation is able to block several key molecular events in prostate cancer progression 69
Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones 69
Assessment of dose exposure and image quality in coronary angiography performed by 640-slice CT: a comparison between adaptive iterative and filtered back-projection algorithm by propensity analysis 69
Challenges to treat hypogonadism in prostate cancer patients: Implications for endocrinologists, urologists and radiotherapists 69
Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer 69
XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa) 68
Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 Prostate Cancer Cell Line 68
Vitamin D protects human endothelial cells from H₂O₂ oxidant injury through the Mek/Erk-Sirt1 axis activation 68
The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells. 68
Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells 67
In vivo efficacy of HER1/EGFR tyrosine kinase inhibition in erlotinib resistant PC3 prostate cancer cells is associated to reduced endothelial cell organization and increased inflammatory infiltration 67
Approccio transotturatorio multiple nel trattamento chirurgico dei prolassi urogenitali completi: Risultati preliminari su riproducibilità e sicurezza 66
Anthracycline‑based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5‑fluorouracil and radiation therapy in surgically resected axillary node‑positive breast cancer 66
Reactivation of androgen receptor and Fas: FASL signalling pathways by azacitidine treatment sensitizes aggressive prostate cancers to hormone manipulation and chemotherapy 66
Blockade of the SDF-1/CXCR4 axis is additive/synergistic with radiotherapy and/or temozolomide treatment both in vitro and in vivo in preclinical models of glioblastoma 66
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 66
Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples. 65
L'aumento di neurotrofine è associato alla progressione del tumore della prostata in un modello animale murino 65
Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay 64
Anti-hormone treatments increase Akt protein expression and activation in prostate cancer 64
Bombesin-dependent Pro-MMP-9 activation in Prostatic Cancer cells requires beta-1 integrin engagement 64
Oral Platelet Gel Supernatant Plus Supportive Medical Treatment Versus Supportive Medical Treatment in the Management of Radiation-induced Oral Mucositis: A Matched Explorative Active Control Trial by Propensity Analysis. 64
LA RIDONDANZA DELLE VIE DI SEGNALAZIONE INTRACELLULARI PI3K-AKT-MTOR INDUCE LA RESISTENZA DI CELLULE DI CANCRO PROSTATICO ALLA TERAPIA ORMONALE ED A CHEMOTERAPICI IN VIVO ED IN VITRO 64
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models 64
Carotid artery plaque characterization with a wide-detector computed tomography using a dedicated post-processing 3D analysis: comparison with histology 64
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results 64
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures 63
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models 63
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice 63
Ruolo della finasteride nel controllo della proliferazione di colture primarie di carcinoma della prostata 63
Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures 63
Crocin from Crocus sativus possesses significantly anti-proliferation effect on human breast and prostate cancer cells 63
TAMSULOSINA E TADALAFIL IN PAZIENTI CON IPERTROFIA PROSTATICA BENIGNA E DISFUNZIONE ERETTILE: NOSTRA ESPERIENZA CON LA TERAPIA COMBINATA A LUNGO TERMINE 63
ATTIVITA’ CHEMIOTATTICA DEGLI OSTEOCLASI, TGF-BETA 1 MEDIATA, SU CELLULE DI CARCINOMA PROSTA-TICO IN VITRO 63
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells 62
Totale 7.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.136
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019685 0 0 0 0 0 0 0 0 0 0 49 636
2019/20201.875 431 9 219 21 9 254 332 33 244 67 19 237
2020/20211.980 33 230 7 244 227 84 266 8 259 96 412 114
2021/20221.574 98 130 331 103 66 66 29 87 98 60 101 405
2022/20234.711 317 268 67 557 485 527 6 287 1.968 40 97 92
2023/20241.144 387 73 49 154 73 302 28 48 5 25 0 0
Totale 14.527